Back to REGN
LOOMIS SAYLES & CO L P REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
8
Latest value
$165.9M
Q3 2026
Peak value
$1.3B
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $1.3B |
| Q4 2025 | $178.6M |
| Q1 2026 | $1.3B |
| Q1 2026 | $180.6M |
| Q2 2026 | $1B |
| Q2 2026 | $144.8M |
| Q3 2026 | $1.1B |
| Q3 2026 | $165.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $165.9M | 218.8K | — | — |
| Q3 2026 | $1.1B | 1.50M | — | — |
| Q2 2026 | $144.8M | 232.2K | — | — |
| Q2 2026 | $1B | 1.63M | — | — |
| Q1 2026 | $180.6M | 233.7K | — | — |
| Q1 2026 | $1.3B | 1.68M | — | — |
| Q4 2025 | $178.6M | 231.3K | — | — |
| Q4 2025 | $1.3B | 1.70M | — | — |